Enovis Corp ENOV

Damien McDonald, Enovis Corporation- Chief Executive Officer (2025 - present). LivaNova PLC- Chief Executive Officer (2017 - 2023) and Chief Operating Officer (2016). Danaher Corporation- Vice President and Group Executive, Professional Consumables (2013 - 2016); Group President of Kerr Corporation (2011 - 2013) and Special Projects (2010). Zimmer Holdings- President, Zimmer Spine (2007 - 2010). Johnson and Johnson (1999 - 2007)- Served in various roles, most recently leading global marketing for J&J's Ethicon business. Other Public Directorships in the Past Five Years- LivaNova PLC (2017 - 2023).

Phillip B. Berry has been Chief Financial Officer since January 1, 2023. He joined the Company (then known as Colfax) in 2020, initially serving as chief financial officer of the medical technology segment, and serving as chief financial officer of the Recon and P&R segments following the Separation. Previously, he spent 18 years in the medical technologies sector with Novartis/Alcon, which included its launch of Alcon as an independent public company in 2019. During his tenure at Alcon, Mr. Berry served in finance leadership roles of increasing responsibility in strategy, operations and business process improvement. Mr. Berry holds a master's degree in business administration from Kennesaw State University.

Terry D. Ross was appointed as Group President, Prevention & Recovery in January 2024. Mr. Ross joined the Company (then known as Colfax) in 2012 as SVP & GM of Colfax Reliability Services and has held a number of leadership roles, including VP of Investor Relations, VP of Strategy & Business Development, and President of the Company's Recovery Sciences and Bracing and Support Businesses. Prior to joining the Company, he served in a number of management roles at Danaher and GE. Mr. Ross earned an MBA from Harvard Business School, graduating as a Baker Scholar, and received a B.S. in Mechanical Engineering from West Virginia University.

Louis Vogt was appointed as Group President, Reconstructive in January 2024. Mr. Vogt joined DJO (now Enovis) in 2017, leading the Surgical Global Product Management Organization before becoming President of the Enovis U.S. surgical business. Prior to joining the Company, he spent 15 years with Zimmer and Zimmer Biomet in various commercial leadership roles spanning sales, marketing and product management across their Recon, Trauma, Sports Medicine, and Ortho Biologics divisions. Mr. Vogt earned his MBA from the University of Notre Dame and a B.S. degree in Business Management from Purdue University.

Effective as of the close of the Annual Meeting, the Board has appointed Sharon Wienbar, who has served as the Lead Independent Director of the Board since May 2023, to serve as independent Chair of the Board. Sharon Wienbar, Scale Venture Partners- Partner (2001 - 2018); Led venture capital investments in technology companies and served on the boards of numerous public and private portfolio businesses. Hackbright Academy, a leading software engineering training company for women- Chief Executive Officer (2015 - 2016). Planned Parenthood Direct (formerly Kaleido Health) (private non-profit company), a leading women's health app- Director (2016 - present). Everyday Health, Inc.- Director (2014 - 2016). Glu Mobile, Inc.- Director (2007 - 2008). Prior to venture capital career, served as an executive at several software companies, including Adobe Systems, and as a consultant at Bain & Company. Served on Microsoft Inc.'s venture advisory committee. Other Current Public Directorships- Resideo Technologies, Inc. and Ingram Micro Holding Corporation. Other Public Directorships in the Past Five Years- Covetrus, Inc. (2020 - 2022)

A. Clayton Perfall, Tailwind Capital (2014 - 2022)- Operating Executive, focused on growing middle market companies in the healthcare, technology, business services and industrial services sectors. Archway Marketing Services, Inc.- Chairman and Chief Executive Officer (2008 - 2013). Union Street Acquisition Corp.- Chief Executive Officer and Director (2006 - 2008). AHL Services, Inc.- Chief Executive Officer and Director (2001 - 2008). Snyder Communications, Inc.- Chief Financial Officer and Director (1996 - 2000). Previously served as a partner with an international accounting firm, and as a director of numerous public and private companies

Ms. Lalor, Danaher Corporation- Advisor (2022 - 2023) and Senior Vice President, Human Resources (2012 - 2022). 3M Company- Senior Vice President, Human Resources (2005 - 2012). Served in a series of human resources leadership roles of progressive responsibility from 1990 - 2004.

Rajiv Vinnakota, Institute for Citizens & Scholars (formerly the Woodrow Wilson National Fellowship Foundation)- President (2019 - present). The Aspen Institute- Executive Vice President (2015 - 2018), leading a division on youth and engagement. The SEED Foundation- Co-Founder and Chief Executive Officer (1997 - 2015) and Director (1997 - present); Chair of the Board (1997 - 2005). Princeton University- Trustee (2004 - 2007); Member, Executive Committee of Board of Directors (2006 - 2007) and National Chair of Annual Giving (2007 - 2009). The Eugene and Agnes Meyer Foundation- Director (2016 - 2019). Previously served as an associate at Mercer Management Consulting. Other Current Public Directorships- ESAB Corporation (2022 - present).

Brady R. Shirley, Enovis Corporation- Executive Advisor (2024 - March 2025); President and Chief Operating Officer (2022 - 2024); Chief Executive Officer, DJO business (2016 - 2022); President, DJO Surgical business (2014 - 2016). National Seating & Mobility (private company)- Chair of the Board of Directors (2023 - present). Innovative Medical Device Solutions- Chief Executive Officer and Director (2009 - 2013). Stryker Corporation (1992 - 2009)- Served in several key leadership positions, including President of Stryker Communications and Senior Vice President of Stryker Endoscopy.

Liam J. Kelly, Teleflex Incorporated- Chairman, President and Chief Executive Officer (2020 - Jan 2026); President and Chief Executive Officer (2018 - 2020) and Served in a variety of senior leadership roles from 2009 to 2017. Hill-Rom Holdings, Inc. (2002 - 2009)- Served in a number of senior level positions, including Vice President of International Marketing and R&D. Other Current Public Directorships- Teleflex Incorporated (2020 - Jan 2026).

Philip Okala, Tufts Medicine- Chief Operating Officer (2023 - present). City of Hope (a leading cancer research and treatment organization)- System President (2022 - 2023). University of Pennsylvania Health System- Chief Operating Officer (2017 - 2022); Senior Vice President for Strategy and Business Development (2013 - 2017) and Vice President for Service Lines (2007 - 2013). Previously held management and leadership positions with other healthcare organizations, including Geisinger Health System, Roswell Park Cancer Institute and the University of Texas MD Anderson Cancer Center. Fellow in the American College of Healthcare Executives and The Healthcare Financial Management Association.

Ms. Bodem, Dentsply Sirona Inc.- Interim Chief Financial Officer (April - October 2022). Hill-Rom Holdings, Inc.- Senior Vice President and Chief Financial Officer (2018 - 2021). Mallinckrodt Pharmaceuticals. BiomEdit (private company)- Director (2022 - present). Northstar Medical Radioisotope (private company)- Director (2024 - present). Previously served in senior finance roles for Hospira, Inc. and Eli Lilly & Company. Other Current Public Directorships- BioMarin Pharmaceutical, Inc. (2023 - present) and Option Care Health, Inc. (2024 - present). Other Public Directorships in the Past Five Years- Syneos Health, Inc. (2022 - 2023) and Turning Point Therapeutics (2021 - 2022).

Dr. Ortiz, Massachusetts Institute of Technology- Professor of Materials Science and Engineering (1999 - present) and Author of more than 210 research publications, supervisor of the research projects of more than 300 individuals, and recipient of 30 national and international honors, including the Presidential Early Career Award in Science and Engineering awarded by President George W. Bush. Founder, president and chair of the board of directors of Station 1 Laboratory, Inc., an innovative, non-profit, research and development higher educational institution. Other Current Public Directorships- Mueller Water Products.

Mr. Kleckner, 45, is a Certified Public Accountant with a Bachelor's Degree in Business Administration and a Master's Degree in Accountancy from Baylor University. His 22-year career includes a senior manager role in the US and Europe at the global firm PricewaterhouseCoopers. Before joining the Company in July 2021, from April 2019 to June 2021, Mr. Kleckner served as Senior Director and Corporate Controller at HMS (Healthcare Management Systems), a healthcare technology company, and, prior to that, from October 2010 to January 2019, in a series of senior financial roles at Denbury Resources, an oil and natural gas company. Mr. Kleckner's background also includes M&A and business improvement initiatives. On February 2, 2022, Colfax Corporation announced the appointment of John Kleckner, as its new principal accounting officer effective May 13, 2022.

Oliver Engert was appointed Chief Administrative Officer in January 2026. Prior to joining the Company, Mr. Engert spent more than 30 years at McKinsey and Company, serving in various senior leadership positions and finishing his tenure with the firm as Senior Partner Emeritus. During his time at McKinsey, Mr. Engert gained extensive experience advising CEOs, other C-suite executives, and boards of directors on strategy, transformations, mergers and acquisitions, organizational design, and performance improvement to deliver significant shareholder value. Mr. Engert holds a bachelor's degree in economics from the Wharton School, University of Pennsylvania, and an MBA from the Amos Tuck School of Business, Dartmouth College.

Bradley J. Tandy has been Senior Vice President and Chief Legal Officer since February 2019, having previously served as Executive Vice President, General Counsel and Secretary of DJO since May 2016. Prior to joining DJO, Mr. Tandy served as Senior Vice President, General Counsel and Secretary of Biomet, Inc. from 2006 through 2014. Prior to serving as General Counsel, Mr. Tandy served as Vice President, Assistant General Counsel and Chief Compliance Officer of Biomet from 1999 through 2006. He joined Biomet as Assistant General Counsel in 1992. Prior to his employment at Biomet, Mr. Tandy was a partner in the law firm of Rasor, Harris, Lemon & Reed in Warsaw, Indiana, focusing his practice on representation of medical device and healthcare companies. He was an elected public official in Kosciusko County, Indiana, serving as a County Councilman for 22 years. He received his undergraduate degree in Political Science from DePauw University and earned his Doctorate of Jurisprudence at Indiana University School of Law in Bloomington, Indiana.

On April 3, 2026, the Company expects to appoint Laura Singleton, Vice President of Human Resources for the Company's Reconstructive segment, as its new Senior Vice President and Chief Human Resources Officer. Ms. Singleton joined the Company in February 2019 in connection with the Company's acquisition of DJO Global, where she had served in vice president of human resources roles since October 2017. Prior to that, she held a series of human resources senior leadership roles at Toppan Photomasks, Inc., Ixia, and Millennium Laboratories. Ms. Singleton earned a B.A. degree in history from Texas State University.